Catalyst
Slingshot members are tracking this event:
Array's (ARRY) NDA for Binimetinib (GX818/MEK162/LGX818) in BRAF Mutant Melanoma (COLUMBUS) Planned for mid 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ARRY |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 05, 2017
Occurred Source:
http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-newsArticle&ID=2284587
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Gx818, Mek162, Lgx818, Vemurafenib, Braf Mutant Melanoma, Columbus
